The COVID-19 pandemic forced a number of changes, many of which will remain in place long after it subsides. One important but under-recognized shift could be in the field of clinical diagnostics.
Modifications and adaptations continue to improve how we use PCR, spurring a new level of creativity in genomics hypotheses and enabling a broad versatility in applications. PCR has the speed, ...
SALT LAKE CITY, Nov. 18, 2025 /PRNewswire/ --Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback